The newly available AmoyDx® Myeloid Blood Cancer Panel enables a comprehensive molecular genetic analysis of 55 genes associated with myeloid leukemia. The analysis on both DNA and RNA level permits the detection of 252 different gene fusions in addition to single nucleotide variants (SNVs), and insertions and deletions (InDels).